TrialJAMA network open2023

Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial.

Donald A Berry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.